Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan
US7041697B2 · kind B2 · utility
1Cited by
3References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 10, 2003 |
| Grant date | May 9, 2006 |
| Priority date | — |
| Expiry date | Jan 28, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the Formula I: are useful for the treatment of depression (including but not limited to major depressive disorder, childhood depression and dysthymia), anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder (also known as pre-menstrual syndrome), attention deficit disorder (with and without hyperactivity), obsessive compulsive disorder, social anxiety disorder, generalized anxiety disorder, obesity, eating disorders such as anorexia nervosa and bulimia nervosa, vasomotor flushing, cocaine and alcohol addiction, sexual dysfunction and related illnesses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.